Increased body fat in these children could increase their risk of cardiovascular disease in the future, and obesity in patients with T1DM increases their risk of developing metabolic syndrome and microvascular complications [25, 26]; therefore, paediatricians need to pay attention to obesity risk in patients receiving insulin therapy. The gene discussed is INS; the disease is type 1 diabetes mellitus.